Tirzepatide 60mg – Best effect and Reviews For Weight Loss Bodybuilding
Original price was: $400.00.$320.00Current price is: $320.00.
Tirzepatide is a pioneering, synthetically engineered 39-amino acid peptide that functions as a dual agonist. >99% purity confirmed by HPLC analysis.
100% delivery
- Satisfaction Guaranteed
- No Hassle Refunds
- Secure Payments
Description
Tirzepatide 60mg GLP-1/GIP Agonist Weight Management Research
Pharmacodynamics
Tirzepatide exerts its physiological influence by simultaneously activating the GLP-1 and GIP receptors. The GLP-1 component suppresses glucagon secretion and delays gastric emptying, while the GIP component??which is highly expressed in adipose tissue??is believed to enhance insulin sensitivity and lipid metabolism. This synergistic interaction initiates a massive signaling cascade in the central nervous system to regulate satiety. Compared to Semaglutide, Tirzepatide’s dual-agonist structure targets the GIP receptor to potentially mitigate the nausea associated with GLP-1 activation while maximizing metabolic throughput. Quantitative research indicates a systemic half-life of approximately 5 days, facilitated by its C20 fatty acid diacid moiety which enables strong albumin binding.
Chemical Properties
- CAS Number: 2023788-19-2
- Molecular Formula: C225H348N48O68
- Molecular Weight: ~4813.5 g/mol
- Purity: >99% (HPLC validated)
- Appearance: Sterile filtered white lyophilized powder
Research Observations
- Research models indicate unmatched suppression of appetite and “food noise” cravings.
- Published research indicates significantly higher rates of adipose reduction compared to single-agonist analogs.
- Aggregated data shows profound stabilization of postprandial blood glucose levels.
- Researchers observe enhanced nutrient partitioning and systemic insulin sensitivity across extended protocols.
About This Compound
Tirzepatide is a pioneering, synthetically engineered 39-amino acid peptide that functions as a dual agonist. Unlike traditional single-target compounds, it mimics two endogenous incretin hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This dual-pathway approach offers researchers an advanced vector for evaluating superior metabolic regulation and adipose tissue reduction.
Summary:
Tirzepatide provides an advanced dual-agonist framework for investigating the synergistic effects of GLP-1 and GIP on metabolic health and weight regulation.
Frequently Asked Questions
[Q] How is Tirzepatide different from Semaglutide?
Semaglutide only targets the GLP-1 receptor, while Tirzepatide targets both the GLP-1 and GIP receptors for a more comprehensive metabolic effect.
[Q] What is the “titration” schedule?
Titration is the process of starting at a very low dose (2.5mg) and slowly increasing it every 4 weeks to allow the body to adjust to the gastric changes.
[Q] Why is GIP important in this peptide?
GIP (Glucose-dependent insulinotropic polypeptide) is believed to help manage fat storage and may reduce some of the nausea caused by GLP-1.
[Q] Does it need to be taken every day?
No, due to its long half-life, community consensus and clinical research dictate a strictly once-per-week administration.
[Q] How long can a reconstituted vial be used?
When mixed with Bacteriostatic Bac.water and kept refrigerated, the solution is generally stable for up to 28 days.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.





